Managing acute chest syndrome of sickle cell disease in an African setting

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue 6, 2008, Pages 526-531

  Fawibe, A E ^a  

^a FEDERAL MEDICAL CENTER   (Nigeria)

Author keywords

Acute chest syndrome; Africa; Analgesics; Hydroxyurea; Nigeria; Sickle cell anaemia

Indexed keywords

ANALGESIC AGENT; ANTICOAGULANT AGENT; CLOTRIMAZOLE; DROXIAL; HEMOGLOBIN; HERBACEOUS AGENT; HYDROXYUREA; MONOCLONAL ANTIBODY; NICOSAN; OXYGEN; STEROID;

ACUTE CHEST SYNDROME; AFRICA; BLOOD CULTURE; BONE MARROW TRANSPLANTATION; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG MECHANISM; DRUG TOLERABILITY; ERYTHROCYTE TRANSFUSION; FEVER; GENOTYPE; HEALTH CARE AVAILABILITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYDRATION; INCIDENCE; INFECTION CONTROL; LEUKOCYTE COUNT; MORBIDITY; MORTALITY; NIGERIA; NONVIRAL GENE THERAPY; OXYGEN BLOOD LEVEL; PATHOGENESIS; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; REVIEW; RISK REDUCTION; SICKLE CELL ANEMIA; SPUTUM CULTURE; THORAX PAIN; THORAX RADIOGRAPHY;

ACUTE DISEASE; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYDROXYUREA; LUNG DISEASES; NIGERIA; PHYTOTHERAPY; PLANT PREPARATIONS; RESPIRATION DISORDERS; SYNDROME;

EID: 43149091179     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.03.018     Document Type: Review

References (44)

1. Ahmed S., Siddiqui A.K., Igbal U., Sison C.P., Shahid R.K., Sheth M., Patel D.V., and Russo L.A. Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report. Eur. J. Haematol. 72 (2004) 213-216
2. Ballack S.K., Files B., Luchtman-Jones, Benjamin L., Swerdlow P., Hilliard L., Coates T., Abboud M., Wojtowicz-Praga S., and Grindel J.M. Safety of purified poloxamer 188 in sickle cell disease: Phase 1 study of a non-ionic surfactant in the management of acute chest syndrome. Hemoglobin 28 (2004) 85-102
3. Bellet P.S., Kalinyak K.A., Shukla R., Gelfand M.J., and Rucknagel D.L. Incentive spirometry to prevent acute pulmonary complications in sickle cell disease. N. Engl. J. Med. 333 (1995) 699-703
4. Bernard A.W., Yasin Z., and Veukat A. Acute chest syndrome of sickle cell disease. Hosp. Physician 44 (2007) 15-23
5. Boyd J.H., Mackling E.A., Strunk R.C., and DeBaun M.R. Asthma is associated with acute chest syndrome and pain in sickle cell anaemia. Blood 108 (2006) 2923-2927
6. Castro O. Pulmonary complications of sickle cell disorders from an adult perspective. Hematol. (1999) 39-44
7. Castro O., Brambilla D.J., Thorington B., Reindorf C.A., Scott R.B., Gillette P., Vera J.C., and Levy P.S. The acute chest syndrome in sickle cell disease: incidence and risk factors. The cooperative study of sickle cell disease. Blood 84 (1994) 643-649
8. Charache S., Scott J.C., and Charache P. "Acute chest syndrome" in adults with sickle cell anaemia: microbiology, treatment and prevention. Arch. Intern. Med. 139 (1979) 67-69
9. Charache S., Terrin M.L., Moore R.D., Dover G.J., Barton F.B., Eckert S.V., McMahon R.P., and Bonds D.R. Effect of hydroxyurea on the frequency of painful crises in sickle cell anaemia. N. Engl. J. Med. 332 (1995) 1317-1322
10. Couillard S., Benkerron M., Girot R., Brousse V., Ferster A., and Bradder-Meunier B. Steroid treatment in children with sickle cell disease. Haematologica 92 (2007) 425-426
11. Edward J.B. Hemoglobinopathies. In: Braunwald E., Hauser S.L., Fauci A.S., Longo D., Kasper D.L., and Jameson J.L. (Eds). Harrison's Principles of Internal Medicine. international ed., 15th ed. (2001), McGraw Hill, New York 666-673
12. Emre U., Miller S.T., Rao S.P., and Rao M. Alveolar-arterial oxygen gradient in acute chest syndrome of sickle cell disease. J. Pediatr. 123 (1993) 272-275
13. Glover R.E., Ivy E.D., Orringer E.P., Maeda H., and Mason R.P. Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anaemia with hydroxyurea. Mol. Pharmacol. 55 (1999) 1006-1010
14. Golden C., Styles L., and Vichinsky E. Acute chest syndrome and sickle cell disease. Curr. Opin. Haematol. 5 (1998) 89-92
15. Gonzalez E.R., Bahal N., Hansen L.A., Ware D., Bull D.S., Ornato J.P., and Lehman M.E. Intermittent injection vs. patient-controlled analgesia for sickle cell crises pain: comparison in patient in the emergency department. Arch. Intern. Med. 151 (1991) 1373-1378
16. Hassell K.L., Eckman J.R., and Lane P.A. Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes. Am. J. Med. 96 (1994) 155-163
17. Haynes Jr. J., and Allison R.C. Pulmonary edema: complication in the management of sickle cell pain crisis. Am. J. Med. 80 (1986) 833-840
18. Ibidapo M.O., and Akinyanju O.O. Acute sickle cell syndromes in Nigerian adults. Clin. Lab. Haem. 22 (2000) 151-154
19. Iyamu E.W., Turner E.A., and Asakura T. In vitro effects of NIPRISAN (Nix-0699): a naturally occurring, potent antisickling agent. Br. J. Haematol. 118 (2002) 337-343
20. Jaja S.I., Opesanwo O., Mojiminiyi F.B.O., and Kehinde M.O. Lung function, haemoglobin F and irreversibly sickle cells in sickle cell patients. W. Afr. J. Med. 19 (2000) 225-229
21. Knight-Madden, J.M., Hambleton, I.R., 2003. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. Cochrane Database Syst. Rev. 3: CD003733. DOI:10.1002/14651858.CD003733.
22. Knight-Madden J.M., Forrester T.S., Lewis N.A., and Greenough A. Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 60 (2005) 206-210
23. Kopecky E.A., Jacobson S., Joshi P., and Koren G. Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease. Clin. Pharmacol. Ther. 75 (2004) 140-146
24. Lawson S.E., Oakley S., Smith N.A., and Bareford D. Red cell exchange in sickle cell disease. Clin. Lab. Haematol. 21 (1999) 99-102
25. Leong C.S., and Stark P. Thoracic manifestations of sickle cell disease. J. Thorac. Imaging 13 (1998) 128-134
26. Mallouh A.A., and Asa A. Beneficial effect of transfusion in children with sickle cell chest syndrome. Am. J. Dis. Child. 142 (1998) 178-184
27. Okomo, U., Meremikwu, M.M., 2007. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. Cochrane Database Syst. Rev. 2: CD005406. DOI:10.1002/14651858.CD005406.Pub2.
28. Olujohungbe, A., Yardumian, A., Cinkotai, K.I., 1998. New treatment strategies for sickle cell disease. Postgraduate Doctor Africa, August 20, 68-74.
29. Pacelli R., Taira J., Cook J.A., Wink D.A., and Krishna M.C. Hydroxyurea reacts with heme proteins to generate nitric oxide. Lancet 347 (1996) 900
30. Perlin E., Finke H., Castro O., Rana S., Pittman J., Burt R., Ruff C., and McHugh D. Infusion/patient-controlled analgesia in sickle cell vaso-occlusive crises. Pain Clinic 6 (1993) 113-119
31. Platt O.S., Brambilla D.J., Rosse W.F., Milner P.F., Castro O., Steinberg M.H., and Klug P.P. Mortality in sickle disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 330 (1994) 1639-1644
32. Setty B.N., and Stuart M.J. Vascular adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood 88 (1996) 3211-3220
33. Stuart M.J., and Setty B.N. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood 94 (1999) 1555-1560
34. 2 levels in acute chest syndrome of sickle cell disease. Blood 87 (1996) 73-78
35. Strouse J.J., Takemoto C.M., Keefer J.R., Kato G.J., and Casella J.F. Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatr. Blood Cancer (2007) 10.1002/pbc.21336
36. Sullivan K.J., Goodwin S.R., Evangelist J., Moore R.D., and Mehta P. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit. Care Med. 27 (1999) 256-368
37. Swerdlow P.S. Red cell exchange in sickle cell disease. Hematol. (2006) 48-53
38. Vichinsky E., and Styles L. Pulmonary complications. Hematol. Oncol. Clin. North Am. 10 (1996) 1275-1287
39. Vichinsky E.P., Styles L.A., Colangelo L.H., Wright E.C., Castro O., and Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative study of sickle cell disease. Blood 89 (1997) 1787-1792
40. Vichinsky E.P., Neumayr L.D., Earles A.N., Williams R., Lennette E.T., Dean D., Nickerson B., McKie V., Bellevue R., Daeschner C., Manci E.A., Abboud M., Moncino M., Ballas S., and Ware R. Causes and outcomes of acute chest syndrome in sickle cell disease: National Acute Chest Syndrome Study Group. N. Engl. J. Med. 342 (2000) 1855-1865
41. Walker B.K., Ballas S.K., and Burka E.R. The diagnosis of pulmonary thromboembolism in sickle cell disease. Am. J. Haematol. 7 (1979) 219-232
42. Walters M.C., Patience M., Leisenring W., Eckman J.R., Scott J.P., Mentzer W.C., Davies S.C., Ohene-Frempong K., Bernaudin F., Matthews D.C., Storb R., and Sullivan K.M. Bone marrow transplantation for sickle cell disease. N. Engl. J. Med. 335 (1996) 369-376
43. Walters, M.C., Quirolo, L., Edwards, S., Lee, J., Robertson, S., Falcon, K., Briddel, R., Quirolo, K.C., Lubin, B., 2007. Sibling donor blood transplantation for hemoglobinopathies. Sickle Cell Disease Association of America and National Institutes of Health 35th Annual Convention; Washington DC; September 2007 [abstract].
44. Weil J.V., Catro O., Malik A.B., Rodgers G., Bonds D.R., and Jacobs T.P. NHLBI Workshop summary: pathogenesis of lung disease in sickle haemoglobinopathies. Am. Rev. Respir. Dis. 148 (1993) 249-256